Novel Anticancer Drug Protocols

With many potential molecular targets of anticancer agents already identified and many more yet to be discovered, the great challenges are now to successfully validate them, to devise relevant assays, and to translate the results into effective medicines for cancer patients. In Novel Anticancer Drug...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Buolamwini, John K. (Editor, http://id.loc.gov/vocabulary/relators/edt), Adjei, Alex A. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Totowa, NJ : Humana Press : Imprint: Humana, 2003.
Edition:1st ed. 2003.
Series:Methods in Molecular Medicine, 85
Subjects:
Online Access:https://doi.org/10.1385/1592593801
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Overview of Novel Anticancer Drug Targets
  • Kinase Inhibitor Discovery Protocols
  • Biomarker Assays for Phosphorylated MAP Kinase
  • Assays for Cyclin-Dependent Kinase Inhibitors
  • Identifying Inhibitors of ATM and ATR Kinase Activities
  • Angiogenesis and Metastasis Protocols
  • The Rat Aortic Ring Assay for In Vitro Study of Angiogenesis
  • Real Time In Vivo Quantitation of Tumor Angiogenesis
  • Use of Tumor-Activated Hepatic Stellate Cell as a Target for the Preclinical Testing of Anti-Angiogenic Drugs Against Hepatic Tumor Development
  • Cell Motility, Adhesion, Homing, and Migration Assays in the Studies of Tyrosine Kinases
  • Inflammatory Response of Tumor-Activated Hepatic Sinusoidal Endothelium as a Target for the Screening of Metastasis Chemopreventive Drugs
  • Binding Assay for Selectins
  • Determination of Peak Serum Levels and Immune Response to the Humanized Anti-Ganglioside Antibody-Interleukin-2 Immunocytokine
  • Immunohistochemical Assays in the Clinical Setting
  • Immunohistochemical Determination of EGFR-Tyrosine Kinase Inhibition in Clinical Samples
  • Immunohistochemical Assays of Farnesyltransferase Inhibition in Patient Samples
  • Protein Chaperoning/Degradation Protocols
  • Assays for HSP90 and Inhibitors
  • Assays for Proteasome Inhibition
  • Protein-Protein and Protein-DNA Interactions
  • The Mammalian Two-Hybrid Assay for Detection of Coactivator-Nuclear Receptor Interactions
  • Preparation of DNA-Protein Complexes Suitable for Spectroscopic Analysis
  • Antisense
  • Antisense Oligonucleotide Inhibitors of MDM2 Oncogene Expression
  • Genomics
  • Pharmacogenetic Analysis of Clinically Relevant Genetic Polymorphisms
  • Gene Expression Microarrays
  • Methods for Isolation and Genetic Analysis of Circulating Tumor DNA in Patient Plasma
  • Cell Lifespan/Longevity
  • The Use of Early Sea Urchin Embryos in Anticancer Drug Testing
  • In Vivo Imaging
  • PET Screening of Anticancer Drugs
  • Miscellaneous Protocols
  • Assays for In Vitro and In Vivo Synergy
  • Flow Cytometric Methods for Detection and Quantification of Apoptosis
  • Assays for Neoplastic Cell Enrichment in Bone Marrow Samples.